The number of people with susceptibility test result for rifampicin in Angola
Angola: The number of people with susceptibility test result for rifampicin was 10,250 in 2021. ◆ Volatile
Latest (2021)
10,250
Change on year
up 836.1%
World rank
21st
of 155 countries
All-time high
29,679
in 2019
All-time low
52
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Angola, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Angola is 10,250, measured in 2021.
That represents a change of up 836.1% on the previous year and up 5,723.9% over five years.
Angola ranks 21st of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Angola, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 176 | — |
| 2018 | 52 | -70.5% |
| 2019 | 29,679 | +56975.0% |
| 2020 | 1,095 | -96.3% |
| 2021 | 10,250 | +836.1% |
Angola compared with similar countries
- Angola's 10,250 is above the median for lower middle income countries, which is 2,804, 3.7× the median. (32 countries reporting)
- Angola's 10,250 is above the median for Sub-Saharan Africa, which is 2,015, 5.1× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 9,969 | 52 | 29,679 | 3 |
| 2020s | 5,672 | 1,095 | 10,250 | 2 |
Countries ranked near Angola
More health data for Angola
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 740.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31,754 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 79 (2025)
- Population ages 00-04, female, annual growth rate 1.97 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0823 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Angola?
- The number of people with susceptibility test result for rifampicin in Angola was 10,250 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Angola?
- The highest recorded value was 29,679 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Angola?
- The lowest recorded value was 52 in 2018.
- How does Angola rank for the number of people with susceptibility test result for rifampicin?
- Angola ranks 21st out of 155 countries with data for 2021.
- Where does this Angola data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).